Interestingly, although the levels of B7.1 and B7.2 in trogocytic cancer cells were comparable to those in CD11b-expressing immune cells within the tumor microenvironment, the transfer of MHC class II molecules was less efficient. The gene discussed is CD86; the disease is neoplasm.